Parkinson's Disease Market Research Reports & Industry Analysis
As the disease progresses, the shaking, or tremor, which affects the majority of PD patients may begin to interfere with daily activities. Other symptoms may include depression and other emotional changes; difficulty in swallowing, chewing, and speaking; urinary problems or constipation; skin problems; and sleep disruptions. There are currently no blood or laboratory tests that have been proven to help in diagnosing sporadic PD. Therefore the diagnosis is based on medical history and a neurological examination. The disease can be difficult to diagnose accurately.
There is no cure for PD, but a variety of medications provide dramatic relief from the symptoms. Usually, patients are given levodopa combined with carbidopa. Carbidopa delays the conversion of levodopa into dopamine until it reaches the brain. Anticholinergics may help control tremor and rigidity. Other drugs, such as bromocriptine, pramipexole, and ropinirole, mimic the role of dopamine in the brain, causing the neurons to react as they would to dopamine. An antiviral drug, amantadine, also appears to reduce symptoms.
Parkinson's Disease Industry Research & Market Reports
-
Neurodegenerative Disease Market, By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, and Other Indication Types), By Drug Type (N-methyl-D-aspartate Receptor antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, and Other Drug Types), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Neurodegenerative disease is a type of disease in which cells of the central ... Read More
-
Global Parkinson's Disease Market Growth (Status and Outlook) 2023-2029
... comprehensive analysis by region and market sector of projected Parkinson's Disease sales for 2023 through 2029. With Parkinson's Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in ... Read More
-
Global Parkinson's Disease Therapeutics Market Growth (Status and Outlook) 2023-2029
... 2022, providing a comprehensive analysis by region and market sector of projected Parkinson's Disease Therapeutics sales for 2023 through 2029. With Parkinson's Disease Therapeutics sales broken down by region, market sector and sub-sector, this report ... Read More
-
Immunoassay for Neurological Biomarkers Market Size, Share & Trends Analysis Report By Product, By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis), By Application, By Region, And Segment Forecasts, 2023 - 2030
... Market Growth & Trends The global immunoassay for neurological biomarkers market size is expected to reach USD 2.24 billion by 2030, registering a CAGR of 17.8% from 2023 to 2030, according to a new report ... Read More
-
Neurodegenerative Drugs Market By Drug Class (Dopamine agonist , Decarboxylase inhibitors , Cholinesterase Inhibitors , Immunomodulators, Others ), By Indication (Parkinson’s Disease, Alzheimer’s Disease, Multiple Sclerosis , Others), By Distribution Channel (Hospital Pharmacies, Online Providers, Drug Stores and Retail Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Drug Stores and Retail Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031 The neurodegenerative drugs market valued for $36,277.20 million in 2021 and is estimated to reach $74,809.38 million by 2031, exhibiting a CAGR of ... Read More
-
Parkinson's Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Parkinson's Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Vocal Biomarkers Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Frequency, Amplitude, Error Rate, Vocal Rise/Fall Time, Phonation Time, Voice Tremor, Pitch); By Indications (Depression, Attention Deficit, Disruptive Behavior Disorders); By Neurological Disorders (Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, Respiratory & Cardiovascular Disorders, Traumatic Brain Injury); By End User (Hospitals & Clinics, Academic & Research); By Region (North America, Europe, Asia Pacific, Middle East & Africa, Latin America)
... Behavior Disorders); By Neurological Disorders (Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, Respiratory & Cardiovascular Disorders, Traumatic Brain Injury); By End User (Hospitals & Clinics, Academic & Research); By Region (North America, Europe, Asia Pacific, Middle ... Read More
-
Global Parkinsons Disease Drugs Market Growth 2023-2029
... is used to transmit messages between the parts of the brain and nerves that control movement. LPI (LP Information)' newest research report, the “Parkinsons Disease Drugs Industry Forecast” looks at past sales and reviews total ... Read More
-
Global Parkinson's Disease Treatments Market Growth (Status and Outlook) 2023-2029
... this disease is mostly symptomatic and almost no curative treatment alternatives are available. LPI (LP Information)' newest research report, the “Parkinson's Disease Treatments Industry Forecast” looks at past sales and reviews total world Parkinson's Disease ... Read More
-
Parkinson's Disease Drugs Market by Drug Class (Decarboxylase Inhibitors, Dopamine Agonists, COMT Inhibitors, MAO-B Inhibitors, Others), by Route of Administration (Oral, Injection, Transdermal), by Age Group (50 or below 50, Above 50 years): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Analysis and Industry Forecast, 2021-2031 The global Parkinson’s disease drugs market was valued at $5,689.12 million in 2021, and is projected to reach $10,402.65 million by 2031, registering a CAGR of 6.2% from 2021 to ... Read More
-
Blood-Brain Barrier Technologies Market Analysis And Forecast To 2032: By Application (Alzheimer Disease, Epilepsy, Parkinson Disease, Multiple Sclerosis, Hunter Syndrome, Brain Cancer), By Technology (Bispecific Antibody RMT Approach, Trojan Horse Approach, Increasing Permeability, Passive Diffusion, Others), By End-Use (Hospitals, Surgical centers, Research Institutes, Others), And Region
... period. Blood-brain barrier (BBB) is one of the main components of the neurovascular unit and serves as the blood-brain interface to mediate communication between the central nervous system and the periphery. It prevents pathogens and ... Read More
-
Neurology Monitoring Market, By Product Type (Magnetic Resonance Imaging (MRI) Devices, Electroencephalography Devices, Cerebral Oximeters, Intracranial Pressure Monitors, and Other Product Types), By Disease Type (Traumatic Brain Injury (TBI), Stroke, Sleep Disorders, Parkinson's Disease, Epilepsy, and Other Diseases), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... and Other Diseases), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Neurology monitoring devices (such as Magnetic Resonance Imaging (MRI) ... Read More
-
Neurotech Devices Market Report 2023-2033
... dynamics. It will be useful for companies that would like to expand into different industries or expand their existing operations in a new region. Growing Number of Elderly Populations with Neurological Disorders The rapidly growing ... Read More
-
Brain Monitoring Market, By Product Type (Magnetoencephalograph, Electroencephalograph Cerebral Oximeters, Functional Magnetic Resonance Imaging (fMRI), Intracranial pressure Monitoring Devices, and Other Product Types), By Application (Parkinson’s Disease, Traumatic Brain Injury Epilepsy, Dementia, and Sleep Disorders Other Applications), By End User (Hospitals and Diagnostic Centers), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... Other Applications), By End User (Hospitals and Diagnostic Centers), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Brain monitoring is ... Read More
-
Deep Brain Stimulation Devices Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018–2028, Segmented By Type (Open Loop DBS, Closed Loop DBS); Distribution Channel (Online, Offline); End User (Hospitals, Specialized Neurology Clinics, Research Centers, Others); Functionality (One-sided Dual Channel Deep Brain Stimulator, Two-sided Dual Channel Deep Brain Stimulator); Application (Parkinson’s Disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder, Others); Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
... Research Centers, Others); Functionality (One-sided Dual Channel Deep Brain Stimulator, Two-sided Dual Channel Deep Brain Stimulator); Application (Parkinson’s Disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder, Others); Region (North America, Europe, Asia Pacific, Latin America, ... Read More
-
SARM1 Targeting Therapeutics Market, 2022-2040
... annually. Further, according to a report published by the United Nations (UN), close to 1 billion people, globally, suffer from various types of neurological disorders, such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis and ... Read More
-
Electrophysiology Market Size By Product (EP Ablation Catheters {Radiofrequency, Cryoablation, Laser}, EP Diagnostic Catheters {Conventional, Advanced, Ultrasound}, EP Laboratory Devices {Mapping Systems, Recording Systems}), By Indication (Atrial Fibrillation, Ventricular Tachycardia, Atrial Tachycardia, Atrial Flutter, WOLFF-Parkinson-White (WPW) Syndrome, Atrioventricular Nodal Reentry Tachycardia), By End-use (Hospitals, Catheterization Laboratories/EP Laboratories, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
... (WPW) Syndrome, Atrioventricular Nodal Reentry Tachycardia), By End-use (Hospitals, Catheterization Laboratories/EP Laboratories, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032 The electrophysiology industry is anticipated ... Read More
-
Parkinson’s Disease Treatment Market Size, Share & Trends Analysis Report By Drug Class (Carbidopa-levodopa, Anticholinergics), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region, And Segment Forecasts, 2022 - 2030
... & Trends The global Parkinson’s disease treatment market size is expected to reach USD 11.98 billion by 2030, according to a new report by Grand View Research, Inc., growing at a CAGR of 12.1% from ... Read More
-
Global Neurodegenerative Disease Market - 2022-2029
... 7.4% during the forecast period (2022-2029). Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s, among others disorders, affect the neurons in the human brain, leading to the inability of neurons to reproduce themselves. Thus, the ... Read More
-
Parkinson's Disease Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Levodopa/carbidopa, Dopamine Receptor Agonists, MAO-Inhibitors, COMT-inhibitors, Anticholinergics, and Other Drugs); By Distribution Channel; By Route of Ad
... Region; Segment Forecast, 2022 - 2030 The global Parkinson’s disease treatment market size is expected to reach USD 7.74 billion by 2030, according to a new study by Polaris Market Research. The report “Parkinson’s Disease ... Read More
-
Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Parkinson's Disease (Central Nervous System) pipeline landscape. Parkinson's disease (PD) is a neurodegenerative disorder characterized by movement dysfunctions. The main finding in brains of people with PD is loss of ... Read More
-
Global X-Ray Detector Market (2022 Edition)– Analysis By Technology, Portability, Application, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2023-2028)
... 5246.84 Million in the year 2021. Major factors driving the market growth include increasing demand for early diagnosis and widening scope of clinical applications of X-ray detectors, growing investments in advancing healthcare facilities & digital ... Read More
-
Neurostimulation Devices Market Size By Product (Transcutaneous Electrical Nerve Stimulation [TENS], Gastric Electric Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Spinal Cord Stimulator, Vagus Nerve Stimulator), By Application (Epilepsy, Essential Tremor, Pain Management, Depression, Dystonia, Urinary and Fecal Incontinence, Parkinson's Disease Gastroparesis,), Industry Analysis Report, Regional Outlook, Covid-19 Impact Analysis, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030
... Urinary and Fecal Incontinence, Parkinson's Disease Gastroparesis,), Industry Analysis Report, Regional Outlook, Covid-19 Impact Analysis, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030 The neurostimulation devices market is poised to witness commendable growth ... Read More
-
Global Neuromodulation Devices Market Size study, by Product (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Transcranial Magnetic Stimulators, Others), by Technology (Internal, External) by Application (Parkinson’s Disease, Chronic Pain, Migraine, Epilepsy, Tremor, Depression, Urinary & Faecal Incontinence, Others) by Biomaterial (Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial) by End-use (Hospitals & Ambulatory Surgery Centers (ASC), Clinics & Physiotherapy Centers, Others) and Regional Forecasts 2022-2028
... Epilepsy, Tremor, Depression, Urinary & Faecal Incontinence, Others) by Biomaterial (Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial) by End-use (Hospitals & Ambulatory Surgery Centers (ASC), Clinics & Physiotherapy Centers, Others) and Regional Forecasts 2022-2028 Global Neuromodulation ... Read More
-
Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027
... an estimated USD 6.0 billion in 2022 and is projected to reach USD 10.4 billion by 2027, at a CAGR of 11.8% during the forecast period. Market growth is driven by factors such as the ... Read More
Research Assistance
